Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32664468 | 1.00 | ALDH1A1 (0.30) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL15939732 | 1.00 | ALDH1A1 (0.30) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL28917443 | 1.00 | ALDH1A1 (0.30) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL29511758 | 0.94 | — | — | |
| SCHEMBL6756409 | 0.94 | TSHR (0.33) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL30577237 | 0.94 | TSHR (0.33) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL379510 | 0.94 | TSHR (0.33) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL7085 | 0.94 | TSHR (0.33) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL3356662 | 0.94 | TSHR (0.33) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL23521060 | 0.88 | ALDH1A1 (0.30) | ALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692247-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260022211-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022211-A1 | CURABLE COMPOSITION | H1-4, H1-0, H1-2 | ALDH1A1 2939/4885TSHR 2520/4885HSD17B10 3742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.